Health Canada
- Status: approved
Indacaterol maleate and glycopyrronium bromide (Indacaterol maleate and glycopyrronium bromide) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Orion Corporation, Orion Pharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.